Medical Technology In India Said To Lag Pharma By 20 Years
This article was originally published in PharmAsia News
India's medical technology today is at a development point occupied by the nation's pharmaceutical industry 20 years ago, a manufacturer says. G.S.K. Velu, managing director of Trivitron Group, said the Indian government has been focusing on the drug industry to the detriment of the medical technology industry, accounting for the lag. His industry, he said, has enjoyed no large-scale initiative such as that provided the drug industry, leaving the market to multinational companies free to trade in India without an Indian presence. (Click here for more
You may also be interested in...
In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.
Concern and skepticism about Russia's rapid vaccine roll-out. Meanwhile Japan is latest to reach reaches deal with Pfizer/BioNTech.
Sun’s Q1 earnings were dented by provisions related to the generic pricing investigation settlement with the US Department of Justice of arm Taro, and the impact of pandemic-related lockdowns. Some clinic-administered products bore the brunt of lock-downs in parts of the US, though market share was unaffected.